Eastman Chemical (EMN) Common Equity (2009 - 2026)

Eastman Chemical has reported Common Equity for 18 years, with the latest figure at $6.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 2.39% year-over-year to $6.1 billion; the trailing twelve-month figure through Mar 2026 stood at $6.1 billion (up 2.39% YoY), and the FY2025 full-year result was $6.0 billion, up 3.16% from the prior year.
• Common Equity for Q1 2026 stood at $6.1 billion, up from $6.0 billion in the prior quarter.
• The five-year high for Common Equity was $6.1 billion in Q1 2026, with the low at -$5.6 billion in Q2 2022.
• Historically, Common Equity has averaged $5.0 billion across 5 years, with a median of $5.7 billion in 2024.
• Annual changes were most pronounced in 2022 — Common Equity plunged 192.44% — and 2023, when it soared 196.05%.
• Eastman Chemical's Common Equity stood at $5.2 billion in 2022, then rose by 5.61% to $5.5 billion in 2023, then grew by 5.82% to $5.9 billion in 2024, then climbed by 3.16% to $6.0 billion in 2025, then gained by 0.81% to $6.1 billion in 2026.
• The last three Common Equity figures came in at $6.1 billion (Q1 2026), $6.0 billion (Q4 2025), and $5.8 billion (Q3 2025), per Business Quant data.